Epigenetic regulation by TOR signaling
TOR 信号传导的表观遗传调控
基本信息
- 批准号:8189085
- 负责人:
- 金额:$ 16.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAffectAntineoplastic AgentsBindingBiochemicalBiologicalCaloric RestrictionCell ProliferationCellsChemicalsChromatinChromatin StructureClinical ResearchComplexCoupledCritical PathwaysCyclic AMP-Dependent Protein KinasesDNADNA Polymerase IDataDiseaseDrug Delivery SystemsEpigenetic ProcessFutureGene ExpressionGene MutationGenesGeneticGenetic ScreeningGenetic TranscriptionGenomicsGoalsHealthHistone H3Histone H4HistonesHumanLeadLibrariesLinkLongevityLysineMalignant NeoplasmsMolecular BiologyMolecular ChaperonesMutationNitrogenNutrientNutritionalPathway interactionsPhosphotransferasesPolymeraseProcessProteinsRNA Polymerase IRNA Polymerase IIRecruitment ActivityRegulationRegulatory PathwayResistanceRibosomal DNARoleSaccharomycetalesScreening procedureSignal PathwaySignal TransductionSirolimusSourceTimeYeast Model Systembasecancer riskcancer therapycell growthchromatin immunoprecipitationchromatin modificationdetection of nutrienthistone acetyltransferaseinhibitor/antagonistmutantnext generationnovelprogramspromoterresponseyeast genetics
项目摘要
DESCRIPTION (provided by applicant): Precise control of cell growth and proliferation in response to nutrient availability is essential for human health. Aberrant regulation of nutrient sensing pathways, either through elevated nutrient availability or genetic mutation, can lead to inappropriate cell growth or proliferation and cause diseases such as cancer. One critical aspect of nutrient signaling is the regulation of a cell's gene expression program. How cells transmit nutrient information to the machinery regulating gene expression is still poorly understood, however. Because DNA is packaged into chromatin, which consists of DNA in a complex with histone proteins, nutrient signaling must regulate chromatin structure to elicit the epigenetic changes necessary to alter gene expression. The studies outlined in this proposal will make use of the budding yeast model system to understand how a critical nutrient signaling cascade, the target of rapamycin (TOR) pathway, regulates epigenetic processes to control gene transcription. Aim I of this project will utilize yeast genetic, molecular biology, and biochemical approaches to delineate how TOR signaling regulates a histone chaperone complex to control RNA polymerase I transcription of ribosomal DNA. Aim II will use a chemical genomics-based approach to find TOR-regulated epigenetic pathways by screening a histone H3 and H4 mutant library in the presence of the TOR inhibitor rapamycin. These mutants will then be combined with mutations in the TOR pathway to further characterize their genetic interactions. In combination, these studies will delineate a novel epigenetic pathway important for RNA polymerase I transcription and will serve to identify new, TOR-regulated epigenetic pathways critical for nutrient regulated cell growth.
PUBLIC HEALTH RELEVANCE: The project's goal is to identify how cells transmit nutrient signals to the epigenetic machinery to regulate gene expression critical for cell growth. Because nutrient signaling pathways are aberrantly regulated in cancer, understanding how they control epigenetic processes will lead to the identification of new anti-cancer drug targets.
描述(由申请人提供):根据营养物质的可用性精确控制细胞生长和增殖对于人类健康至关重要。营养感应途径的异常调节,无论是通过提高营养可用性还是基因突变,都可能导致细胞生长或增殖不当,并导致癌症等疾病。营养信号传导的一个关键方面是细胞基因表达程序的调节。然而,细胞如何将营养信息传递给调节基因表达的机制仍然知之甚少。由于 DNA 被包装到染色质中,而染色质由 DNA 与组蛋白的复合物组成,因此营养信号传导必须调节染色质结构,以引发改变基因表达所需的表观遗传变化。该提案中概述的研究将利用芽殖酵母模型系统来了解关键的营养信号级联(雷帕霉素(TOR)途径的目标)如何调节表观遗传过程以控制基因转录。该项目的目标 I 将利用酵母遗传学、分子生物学和生化方法来描述 TOR 信号传导如何调节组蛋白伴侣复合物以控制核糖体 DNA 的 RNA 聚合酶 I 转录。 Aim II 将使用基于化学基因组学的方法,通过在 TOR 抑制剂雷帕霉素存在的情况下筛选组蛋白 H3 和 H4 突变体库来寻找 TOR 调节的表观遗传途径。然后,这些突变体将与 TOR 通路中的突变相结合,以进一步表征它们的遗传相互作用。结合起来,这些研究将描绘出对 RNA 聚合酶 I 转录很重要的新表观遗传途径,并将有助于识别对营养调节细胞生长至关重要的新的 TOR 调节的表观遗传途径。
公共健康相关性:该项目的目标是确定细胞如何将营养信号传递到表观遗传机制,以调节对细胞生长至关重要的基因表达。由于营养信号通路在癌症中受到异常调节,了解它们如何控制表观遗传过程将有助于识别新的抗癌药物靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald Laribee其他文献
Ronald Laribee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald Laribee', 18)}}的其他基金
Mechanisms of Target of Rapamycin Complex 1 Dependent Epigenetic Regulation
雷帕霉素复合物1依赖的表观遗传调控靶点机制
- 批准号:
10653258 - 财政年份:2022
- 资助金额:
$ 16.26万 - 项目类别:
Mechanisms of Target of Rapamycin Complex 1 Dependent Epigenetic Regulation
雷帕霉素复合物1依赖的表观遗传调控靶点机制
- 批准号:
10515603 - 财政年份:2022
- 资助金额:
$ 16.26万 - 项目类别:
Endolysosomal-nuclear communication mediated through V-ATPase and NHE9 dependent epigenetic signaling
通过 V-ATP 酶和 NHE9 依赖的表观遗传信号介导的内溶酶体-核通讯
- 批准号:
9759328 - 财政年份:2019
- 资助金额:
$ 16.26万 - 项目类别:
Mechanisms of transcription coregulator usage by the target of rapamycin pathway
雷帕霉素通路靶标使用转录共调节因子的机制
- 批准号:
9109664 - 财政年份:2013
- 资助金额:
$ 16.26万 - 项目类别:
Mechanisms of transcription coregulator usage by the target of rapamycin pathway
雷帕霉素通路靶标使用转录共调节因子的机制
- 批准号:
8552300 - 财政年份:2013
- 资助金额:
$ 16.26万 - 项目类别:
Role of Histone H3 Lysine 36 Methylation in Chromatin
组蛋白 H3 赖氨酸 36 甲基化在染色质中的作用
- 批准号:
6883418 - 财政年份:2005
- 资助金额:
$ 16.26万 - 项目类别:
Role of Histone H3 Lysine 36 Methylation in Chromatin
组蛋白 H3 赖氨酸 36 甲基化在染色质中的作用
- 批准号:
7050183 - 财政年份:2005
- 资助金额:
$ 16.26万 - 项目类别:
相似国自然基金
社会网络关系对公司现金持有决策影响——基于共御风险的作用机制研究
- 批准号:72302067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高尿酸调控TXNIP驱动糖代谢重编程影响巨噬细胞功能
- 批准号:82370895
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
倒装芯片超声键合微界面结构演变机理与影响规律
- 批准号:52305599
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
寒地城市学区建成环境对学龄儿童心理健康的影响机制与规划干预路径研究
- 批准号:52378051
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
原位研究聚变燃料纯化用Pd-Ag合金中Ag对辐照缺陷演化行为的影响及其相互作用机制
- 批准号:12305308
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Project 1: Overcoming therapeutic resistance in pancreatic cancer through epigenetic reprogramming
项目1:通过表观遗传重编程克服胰腺癌的治疗耐药性
- 批准号:
10629063 - 财政年份:2023
- 资助金额:
$ 16.26万 - 项目类别:
Deve inlopment of A High-Throughput Screen for Identification of Targeted Therapies in Brainstem Tumors with the H3K27M Mutation
开发用于鉴定 H3K27M 突变脑干肿瘤靶向治疗的高通量筛选
- 批准号:
10192036 - 财政年份:2021
- 资助金额:
$ 16.26万 - 项目类别:
Deve inlopment of A High-Throughput Screen for Identification of Targeted Therapies in Brainstem Tumors with the H3K27M Mutation
开发用于鉴定 H3K27M 突变脑干肿瘤靶向治疗的高通量筛选
- 批准号:
10192036 - 财政年份:2021
- 资助金额:
$ 16.26万 - 项目类别:
Endolysosomal-nuclear communication mediated through V-ATPase and NHE9 dependent epigenetic signaling
通过 V-ATP 酶和 NHE9 依赖的表观遗传信号介导的内溶酶体-核通讯
- 批准号:
9759328 - 财政年份:2019
- 资助金额:
$ 16.26万 - 项目类别:
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
1/2 药物开发和能力建设:UCR/CoH-CCC 合作伙伴关系
- 批准号:
10006525 - 财政年份:2019
- 资助金额:
$ 16.26万 - 项目类别: